The DOI matches its Crossref record; 222 of the 222 references it cites were found in a registry or an index.
The renin-angiotensin-aldosterone system and its suppression
Open accessAbstract
Chronic activation of the renin-angiotensin-aldosterone system (RAAS) promotes and perpetuates the syndromes of congestive heart failure, systemic hypertension, and chronic kidney disease. Excessive circulating and tissue angiotensin II (AngII) and aldosterone levels lead to a pro-fibrotic, -inflammatory, and -hypertrophic milieu that causes remodeling and dysfunction in cardiovascular and renal tissues. Understanding of the role of the RAAS in this abnormal pathologic remodeling has grown over the past few decades and numerous medical therapies aimed at suppressing the RAAS have been developed. Despite this, morbidity from these diseases remains high. Continued investigation into the complexities of the RAAS should help clinicians modulate (suppress or enhance) components of this system and improve quality of life and survival. This review focuses on updates in our understanding of the RAAS and the pathophysiology of AngII and aldosterone excess, reviewing what is known about its suppression in cardiovascular and renal diseases, especially in the cat and dog.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure
Pitt, B., Zannad, F., Remme, W. J., Cody, R., Castaigne, A., Perez, A., Palensky, J., & Wittes, J. (1999) · New England Journal of Medicine · doi:10.1056/nejm199909023411001 · Cited by 9,214
Self-citationThe SOLVD Investigators* (1991) · New England Journal of Medicine · doi:10.1056/nejm199108013250501 · Cited by 8,029
Angiotensin-neprilysin inhibition versus enalapril in heart failure
McMurray, J. J. V., Packer, M., Desai, A. S., Gong, J., Lefkowitz, M. P., Rizkala, A. R., Rouleau, J. L., Shi, V. C., Solomon, S. D., Swedberg, K., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1409077 · Cited by 6,957
Effects of Enalapril on Mortality in Severe Congestive Heart Failure
The Consensus Trial Study Group* (1987) · New England Journal of Medicine · doi:10.1056/nejm198706043162301 · Cited by 5,121
Pitt, B., Remme, W., Zannad, F., Neaton, J., Martinez, F., Roniker, B., Bittman, R., Hurley, S., Kleiman, J., & Gatlin, M. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa030207 · Cited by 4,941
Self-citationSwedberg, K., & Kjekshus, J. (1988) · The American Journal of Cardiology · doi:10.1016/s0002-9149(88)80087-0 · Cited by 3,762
Eplerenone in patients with systolic heart failure and mild symptoms
Zannad, F., McMurray, J. J. V., Krum, H., van Veldhuisen, D. J., Swedberg, K., Shi, H., Vincent, J., Pocock, S. J., & Pitt, B. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1009492 · Cited by 3,111 · cited 1×
“190 Of these 229 dogs ( all Cavalier King Charles Spaniels Three large human studies 197 – 199 have shown a clear benefit from the inclusion of broader RAAS suppressive therapy in the treatment of HFrEF with the addition of an MRA to standard treatment, including an ACEI or ARB.”
Self-citationSpironolactone for heart failure with preserved ejection fraction
Pitt, B., Pfeffer, M. A., Assmann, S. F., Boineau, R., Anand, I. S., Claggett, B., Clausell, N., Desai, A. S., Diaz, R., Fleg, J. L., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1313731 · Cited by 2,809
Self-citationMcMurray, J. J., Östergren, J., Swedberg, K., Granger, C. B., Held, P., Michelson, E. L., Olofsson, B., Yusuf, S., & Pfeffer, M. A. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14283-3 · Cited by 2,604
Weber, K. T., & Brilla, C. G. (1991) · Circulation · doi:10.1161/01.cir.83.6.1849 · Cited by 2,027
Pfeffer, M. A., Swedberg, K., Granger, C. B., Held, P., McMurray, J. J., Michelson, E. L., Olofsson, B., Östergren, J., & Yusuf, S. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14282-1 · Cited by 1,889
Maschio, G., Alberti, D., Janin, G., Locatelli, F., Mann, J. F. E., Motolese, M., Ponticelli, C., Ritz, E., & Zucchelli, P. (1996) · New England Journal of Medicine · doi:10.1056/nejm199604113341502 · Cited by 1,766
Angiotensin-converting enzyme 2 is an essential regulator of heart function
Crackower, M. A., Sarao, R., Oudit, G. Y., Yagil, C., Kozieradzki, I., Scanga, S. E., Oliveira-dos-Santos, A. J., da Costa, J., Zhang, L., Pei, Y., et al. (2002) · Nature · doi:10.1038/nature00786 · Cited by 1,733
(2010) · Cited by 1,697
Mineralocorticoid action: target tissue specificity is enzyme, not receptor, mediated
Funder, J. W., Pearce, P. T., Smith, R., & Smith, A. I. (1988) · Science · doi:10.1126/science.2845584 · Cited by 1,628
Francis, G. S., Benedict, C., Johnstone, D. E., Kirlin, P. C., Nicklas, J., Liang, C. S., Kubo, S. H., Rudin-Toretsky, E., & Yusuf, S. (1990) · Circulation · doi:10.1161/01.cir.82.5.1724 · Cited by 1,388
Williams, B., MacDonald, T. M., Morant, S., Webb, D. J., Sever, P., McInnes, G., Ford, I., Cruickshank, J. K., Caulfield, M. J., Salsbury, J., et al. (2015) · The Lancet · doi:10.1016/s0140-6736(15)00257-3 · Cited by 1,308
Nguyen, G., Delarue, F., Burcklé, C., Bouzhir-Sima, L., Giller, T., & Sraer, J. (2002) · Journal of Clinical Investigation · doi:10.1172/jci14276 · Cited by 1,276
Midwife-led continuity models versus other models of care for childbearing women
Sandall, J., Soltani, H., Gates, S., Shennan, A., & Devane, D. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004667.pub3 · Cited by 1,226
Swedberg, K., Eneroth, P., Kjekshus, J., & Wilhelmsen, L. (1990) · Circulation · doi:10.1161/01.cir.82.5.1730 · Cited by 1,153
Nguyen, G., Delarue, F., Burcklé, C., Bouzhir, L., Giller, T., & Sraer, J.-D. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0214276 · Cited by 1,137
Defective Cardiac Parasympathetic Control in Patients with Heart Disease
Eckberg, D. L., Drabinsky, M., & Braunwald, E. (1971) · New England Journal of Medicine · doi:10.1056/nejm197110142851602 · Cited by 953
WRITING COMMITTEE MEMBERS, Yancy, C. W., Jessup, M., Bozkurt, B., Butler, J., Casey, D. E., Colvin, M. M., Drazner, M. H., Filippatos, G., Fonarow, G. C., et al. (2016) · Circulation · doi:10.1161/cir.0000000000000435 · Cited by 897
Urata, H., Kinoshita, A., Misono, K. S., Bumpus, F. M., & Husain, A. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)45712-2 · Cited by 880
Lassègue, B., Sorescu, D., Szöcs, K., Yin, Q., Akers, M., Zhang, Y., Grant, S. L., Lambeth, J. D., & Griendling, K. K. (2001) · Circulation Research · doi:10.1161/hh0901.090299 · Cited by 839
Role of the ACE2/angiotensin 1-7 axis of the renin-angiotensin system in heart failure
Patel, V. B., Zhong, J.-C., Grant, M. B., & Oudit, G. Y. (2016) · Circulation Research · doi:10.1161/circresaha.116.307708 · Cited by 833
Anker, S. D., Chua, T. P., Ponikowski, P., Harrington, D., Swan, J. W., Kox, W. J., Poole-Wilson, P. A., & Coats, A. J. S. (1997) · Circulation · doi:10.1161/01.cir.96.2.526 · Cited by 800
Aldosterone in Congestive Heart Failure
Weber, K. T. (2001) · New England Journal of Medicine · doi:10.1056/nejmra000050 · Cited by 770
Brown, S., Atkins, C., Bagley, R., Carr, A., Cowgill, L., Davidson, M., Egner, B., Elliott, J., Henik, R., Labato, M., et al. (2007) · Journal of Veterinary Internal Medicine · doi:10.1111/j.1939-1676.2007.tb03005.x · Cited by 748
Self-citationEdelmann, F., Wachter, R., Schmidt, A. G., Kraigher-Krainer, E., Colantonio, C., Kamke, W., Duvinage, A., Stahrenberg, R., Durstewitz, K., Löffler, M., et al. (2013) · JAMA · doi:10.1001/jama.2013.905 · Cited by 746
Dewald, O., Zymek, P., Winkelmann, K., Koerting, A., Ren, G., Abou-Khamis, T., Michael, L. H., Rollins, B. J., Entman, M. L., & Frangogiannis, N. G. (2005) · Circulation Research · doi:10.1161/01.res.0000163017.13772.3a · Cited by 719
Kunz, R., Friedrich, C., Wolbers, M., & Mann, J. F. E. (2008) · Annals of Internal Medicine · doi:10.7326/0003-4819-148-1-200801010-00190 · Cited by 717
Efficacy and Safety of Benazepril for Advanced Chronic Renal Insufficiency
Hou, F. F., Zhang, X., Zhang, G. H., Xie, D., Chen, P. Y., Zhang, W. R., Jiang, J. P., Liang, M., Wang, G. B., Liu, Z. R., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa053107 · Cited by 710
Pitt, B., Wj, R., Zannad, F. M., Neaton, J. D., Martínez, F. A., Roniker, B., Bittman, R. M., Hurley, S., Kleiman, J. H., & Gatlin, M. R. (2003) · Cited by 708
Self-citationMcKelvie, R. S., Yusuf, S., Pericak, D., Avezum, A., Burns, R. J., Probstfield, J., Tsuyuki, R. T., White, M., Rouleau, J., Latini, R., et al. (1999) · Circulation · doi:10.1161/01.cir.100.10.1056 · Cited by 692
Remodeling of the rat right and left ventricles in experimental hypertension.
Brilla, C. G., Pick, R., Tan, L. B., Janicki, J. S., & Weber, K. T. (1990) · Circulation Research · doi:10.1161/01.res.67.6.1355 · Cited by 674
Yusuf, S., Pepine, C. J., Garces, C., Pouleur, H., Rousseau, M., Salem, D., Kostis, J., Benedict, C., Bourassa, M., & Pitt, B. (1992) · The Lancet · doi:10.1016/0140-6736(92)92889-n · Cited by 666
Self-citationMechanisms of progression and regression of renal lesions of chronic nephropathies and diabetes
Remuzzi, G. (2006) · Journal of Clinical Investigation · doi:10.1172/jci27699 · Cited by 618
Levine, T. B., Francis, G. S., Goldsmith, S. R., Simon, A. B., & Cohn, J. N. (1982) · The American Journal of Cardiology · doi:10.1016/0002-9149(82)90243-0 · Cited by 614
Yancy, C. W., Jessup, M., Bozkurt, B., Butler, J., Casey, D. E., Colvin, M. M., Drazner, M. H., Filippatos, G., Fonarow, G. C., Givertz, M. M., et al. (2016) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2016.05.011 · Cited by 613
Angiotensin II-forming pathways in normal and failing human hearts.
Urata, H., Healy, B., Stewart, R. W., Bumpus, F. M., & Husain, A. (1990) · Circulation Research · doi:10.1161/01.res.66.4.883 · Cited by 579
Untreated heart failure: clinical and neuroendocrine effects of introducing diuretics.
Bayliss, J., Norell, M., Canepa-Anson, R., Sutton, G., & Poole-Wilson, P. (1987) · Heart · doi:10.1136/hrt.57.1.17 · Cited by 509
Mineralocorticoid excess, dietary sodium, and myocardial fibrosis.
Brilla, C. G., & Weber, K. T. (1992) · PubMed · Cited by 505
Effectiveness of Aldosterone Blockade in Patients With Diabetic Nephropathy
Sato, A., Hayashi, K., Naruse, M., & Saruta, T. (2003) · Hypertension · doi:10.1161/01.hyp.0000044937.95080.e9 · Cited by 466
Zhong, J., Basu, R., Guo, D., Chow, F. L., Byrns, S., Schuster, M., Loibner, H., Wang, X.-H., Penninger, J. M., Kassiri, Z., et al. (2010) · Circulation · doi:10.1161/circulationaha.110.955369 · Cited by 457
Myocardial Production of Aldosterone and Corticosterone in the Rat
Silvestre, J.-S., Robert, V., Heymes, C., Aupetit-Faisant, B., Mouas, C., Moalic, J.-M., Swynghedauw, B., & Delcayre, C. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.9.4883 · Cited by 446
Mortara, A., La Rovere, M. T., Pinna, G. D., Prpa, A., Maestri, R., Febo, O., Pozzoli, M., Opasich, C., & Tavazzi, L. (1997) · Circulation · doi:10.1161/01.cir.96.10.3450 · Cited by 443
Mineralocorticoids, hypertension, and cardiac fibrosis.
Young, M., Fullerton, M., Dilley, R., & Funder, J. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117269 · Cited by 437
The incidence and implications of aldosterone breakthrough
Bomback, A. S., & Klemmer, P. J. (2007) · Nature Clinical Practice Nephrology · doi:10.1038/ncpneph0575 · Cited by 420
Cellular localization and regional distribution of an angiotensin II-forming chymase in the heart.
Urata, H., Boehm, K. D., Philip, A., Kinoshita, A., Gabrovsek, J., Bumpus, F. M., & Husain, A. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116325 · Cited by 398
Usher, M. G., Duan, S. Z., Ivaschenko, C. Y., Frieler, R. A., Berger, S., Schütz, G., Lumeng, C. N., & Mortensen, R. M. (2010) · Journal of Clinical Investigation · doi:10.1172/jci41080 · Cited by 383
Identification of functional angiotensin II receptors on rat cardiac fibroblasts.
Villarreal, F. J., Kim, N. N., Ungab, G. D., Printz, M. P., & Dillmann, W. H. (1993) · Circulation · doi:10.1161/01.cir.88.6.2849 · Cited by 369
Maggioni, A. P., Anand, I., Gottlieb, S. O., Latini, R., Tognoni, G., & Cohn, J. N. (2002) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(02)02304-5 · Cited by 356
Tissue Renin-Angiotensin-Aldosterone Systems: Targets for Pharmacological Therapy
Bader, M. (2010) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.010909.105610 · Cited by 345
Rise in plasma concentration of aldosterone during long-term angiotensin II suppression
STAESSEN, J., LIJNEN, P., FAGARD, R., VERSCHUEREN, L. J., & AMERY, A. (1981) · Journal of Endocrinology · doi:10.1677/joe.0.0910457 · Cited by 339
Gheorghiade, M., Böhm, M., Greene, S. J., Fonarow, G. C., Lewis, E. F., Zannad, F., Solomon, S. D., Baschiera, F., Botha, J., Hua, T. A., et al. (2013) · JAMA · doi:10.1001/jama.2013.1954 · Cited by 328
Jaisser, F., & Farman, N. (2016) · Pharmacological Reviews · doi:10.1124/pr.115.011106 · Cited by 327
Boswood, A., Häggström, J., Gordon, S. G., Wess, G., Stepien, R. L., Oyama, M. A., Keene, B. W., Bonagura, J., MacDonald, K. A., Patteson, M., et al. (2016) · Journal of Veterinary Internal Medicine · doi:10.1111/jvim.14586 · Cited by 325
Cardiac hypertrophy-induced changes in mRNA levels for TGF-beta 1, fibronectin, and collagen
Villarreal, F. J., & DILLMANN, W. H. (1992) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1992.262.6.h1861 · Cited by 320
Effects of Aldosterone on the Vasculature
Schiffrin, E. L. (2006) · Hypertension · doi:10.1161/01.hyp.0000201443.63240.a7 · Cited by 303
Rickard, A. J., Morgan, J., Tesch, G., Funder, J. W., Fuller, P. J., & Young, M. J. (2009) · Hypertension · doi:10.1161/hypertensionaha.109.131110 · Cited by 303
Update on tissue renin–angiotensin systems
Bader, M., & Ganten, D. (2008) · Journal of Molecular Medicine · doi:10.1007/s00109-008-0336-0 · Cited by 293
Häggström, J., Boswood, A., O'Grady, M., Jöns, O., Smith, S., Swift, S., Borgarelli, M., Gavaghan, B., Kresken, J.-G., Patteson, M., et al. (2008) · Journal of Veterinary Internal Medicine · doi:10.1111/j.1939-1676.2008.0150.x · Cited by 292
Larivière, R., Thibault, G., & Schiffrin, E. L. (1993) · Hypertension · doi:10.1161/01.hyp.21.3.294 · Cited by 282
Biochemical evaluation of the renin-angiotensin system: the good, bad, and absolute?
Chappell, M. C. (2016) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00618.2015 · Cited by 280
Brilla, C. G., Matsubara, L. S., & Weber, K. T. (1993) · The American Journal of Cardiology · doi:10.1016/0002-9149(93)90239-9 · Cited by 278
Mottram, P. M., Haluska, B., Leano, R., Cowley, D., Stowasser, M., & Marwick, T. H. (2004) · Circulation · doi:10.1161/01.cir.0000138680.89536.a9 · Cited by 278
Spironolactone Metabolites in TOPCAT — New Insights into Regional Variation
de Denus, S., O’Meara, E., Desai, A. S., Claggett, B., Lewis, E. F., Leclair, G., Jutras, M., Lavoie, J., Solomon, S. D., Pitt, B., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmc1612601 · Cited by 275
Self-citationSyme, H. M., Markwell, P. J., Pfeiffer, D., & Elliott, J. (2006) · Journal of Veterinary Internal Medicine · doi:10.1111/j.1939-1676.2006.tb02892.x · Cited by 275
Dzau, V. J., Bernstein, K., Celermajer, D., Cohen, J., Dahlöf, B., Deanfield, J., Diez, J., Drexler, H., Ferrari, R., van Gilst, W., et al. (2001) · The American Journal of Cardiology · doi:10.1016/s0002-9149(01)01878-1 · Cited by 259
Schjoedt, K. J., Andersen, S., Rossing, P., Tarnow, L., & Parving, H.-H. (2004) · Diabetologia · doi:10.1007/s00125-004-1542-0 · Cited by 249
Roig, E. (2000) · European Heart Journal · doi:10.1053/euhj.1999.1740 · Cited by 249
Aliskiren, Enalapril, or Aliskiren and Enalapril in Heart Failure
McMurray, J. J. V., Krum, H., Abraham, W. T., Dickstein, K., Køber, L. V., Desai, A. S., Solomon, S. D., Greenlaw, N., Ali, M. A., Chiang, Y., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1514859 · Cited by 249
Tsybouleva, N., Zhang, L., Chen, S., Patel, R., Lutucuta, S., Nemoto, S., DeFreitas, G., Entman, M., Carabello, B. A., Roberts, R., et al. (2004) · Circulation · doi:10.1161/01.cir.0000121426.43044.2b · Cited by 232
Calhoun, D. A., White, W. B., Krum, H., Guo, W., Bermann, G., Trapani, A., Lefkowitz, M. P., & Ménard, J. (2011) · Circulation · doi:10.1161/circulationaha.111.029892 · Cited by 227
Efficacy and tolerability of eplerenone and losartan in hypertensive black and white patients
Flack, J. M., Oparil, S., Pratt, J. H., Roniker, B., Garthwaite, S., Kleiman, J. H., Yang, Y., Krause, S. L., Workman, D., & Saunders, E. (2003) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(03)00054-8 · Cited by 224
Jacob, F., Polzin, D. J., Osborne, C. A., Neaton, J. D., Kirk, C. A., Allen, T. A., & Swanson, L. L. (2005) · Journal of the American Veterinary Medical Association · doi:10.2460/javma.2005.226.393 · Cited by 222
Suzuki, G., Morita, H., Mishima, T., Sharov, V. G., Todor, A., Tanhehco, E. J., Rudolph, A. E., McMahon, E. G., Goldstein, S., & Sabbah, H. N. (2002) · Circulation · doi:10.1161/01.cir.0000039104.56479.42 · Cited by 218
Dell'Italia, L. J., Meng, Q. C., Balcells, E., Wei, C. C., Palmer, R., Hageman, G. R., Durand, J., Hankes, G. H., & Oparil, S. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119529 · Cited by 216
Harada, E., Yoshimura, M., Yasue, H., Nakagawa, O., Nakagawa, M., Harada, M., Mizuno, Y., Nakayama, M., Shimasaki, Y., Ito, T., et al. (2001) · Circulation · doi:10.1161/01.cir.104.2.137 · Cited by 211
Efficacy of Eplerenone Added to Renin-Angiotensin Blockade in Hypertensive Patients
Krum, H., Nolly, H., Workman, D., He, W., Roniker, B., Krause, S., & Fakouhi, K. (2002) · Hypertension · doi:10.1161/01.hyp.0000025146.19104.fe · Cited by 210
Chappell, M. C. (2007) · Hypertension · doi:10.1161/hypertensionaha.106.076216 · Cited by 206
Pitt, B. (1995) · Cardiovascular Drugs and Therapy · doi:10.1007/bf00877755 · Cited by 205
Self-citationMacFadyen, R. J., Lee, A. F. C., Morton, J. J., Pringle, S. D., & Struthers, A. D. (1999) · Heart · doi:10.1136/hrt.82.1.57 · Cited by 205
Beneficial neurohormonal profile of spironolactone in severe congestive heart failure
Rousseau, M. F., Gurné, O., Duprez, D., Van Mieghem, W., Robert, A., Ahn, S., Galanti, L., & Ketelslegers, J.-M. (2002) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(02)02382-3 · Cited by 200
Matsumoto, T., Wada, A., Tsutamoto, T., Ohnishi, M., Isono, T., & Kinoshita, M. (2003) · Circulation · doi:10.1161/01.cir.0000074041.81728.79 · Cited by 200
Amazit, L., Le Billan, F., Kolkhof, P., Lamribet, K., Viengchareun, S., Fay, M. R., Khan, J. A., Hillisch, A., Lombès, M., Rafestin-Oblin, M.-E., et al. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.657957 · Cited by 196
Roles of Angiotensin Peptides and Recombinant Human ACE2 in Heart Failure
Basu, R., Poglitsch, M., Yogasundaram, H., Thomas, J., Rowe, B. H., & Oudit, G. Y. (2017) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2016.11.064 · Cited by 196
Pathophysiology of Spironolactone-Induced Gynecomastia
ROSE, L. I., UNDERWOOD, R. H., NEWMARK, S. R., KISCH, E. S., & WILLIAMS, G. H. (1977) · Annals of Internal Medicine · doi:10.7326/0003-4819-87-4-398 · Cited by 193
Mori, J., Patel, V. B., Abo Alrob, O., Basu, R., Altamimi, T., DesAulniers, J., Wagg, C. S., Kassiri, Z., Lopaschuk, G. D., & Oudit, G. Y. (2014) · Circulation: Heart Failure · doi:10.1161/circheartfailure.113.000672 · Cited by 192
Mouse angiotensin-converting enzyme is a protein composed of two homologous domains
Bernstein, K. E., Martin, B. M., Edwards, A. S., & Bernstein, E. A. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)80158-2 · Cited by 189
Aldosterone antagonists for preventing the progression of chronic kidney disease
Bolignano, D., Palmer, S. C., Navaneethan, S. D., & Strippoli, G. F. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007004.pub3 · Cited by 189
Nagata, S., Kato, J., Sasaki, K., Minamino, N., Eto, T., & Kitamura, K. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.09.146 · Cited by 182
Guyton, A. C. (1990) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.1990.259.5.r865 · Cited by 180
Pressure natriuresis and the renal control of arterial blood pressure
Ivy, J. R., & Bailey, M. A. (2014) · The Journal of Physiology · doi:10.1113/jphysiol.2014.271676 · Cited by 177
Iglarz, M., Touyz, R. M., Viel, É. C., Amiri, F., & Schiffrin, E. L. (2004) · American Journal of Hypertension · doi:10.1016/s0895-7061(04)00811-8 · Cited by 172
Kvart, C., Häggström, J., Pedersen, H. D., Hansson, K., Eriksson, A., Järvinen, A.-K., Tidholm, A., Bsenko, K., Ahlgren, E., Lives, M., et al. (2002) · Journal of Veterinary Internal Medicine · doi:10.1111/j.1939-1676.2002.tb01610.x · Cited by 171
Production of Aldosterone in Isolated Rat Blood Vessels
Takeda, Y., Miyamori, I., Yoneda, T., Iki, K., Hatakeyama, H., Blair, I. A., Hsieh, F.-Y., & Takeda, R. (1995) · Hypertension · doi:10.1161/01.hyp.25.2.170 · Cited by 168
Aldosterone mediates its rapid effects in vascular endothelial cells through GPER activation
Gros, R., Ding, Q., Liu, B., Chorazyczewski, J., & Feldman, R. D. (2013) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00203.2012 · Cited by 166
Aldosterone antagonists for preventing the progression of chronic kidney disease
Navaneethan, S. D., Nigwekar, S. U., & Strippoli, G. F. (2008) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007004 · Cited by 166
Gilbert, K. C., & Brown, N. J. (2010) · Current Opinion in Endocrinology, Diabetes & Obesity · doi:10.1097/med.0b013e3283391989 · Cited by 161
Chronic administration of aldosterone depresses baroreceptor reflex function in the dog.
Wang, W. (1994) · Hypertension · doi:10.1161/01.hyp.24.5.571 · Cited by 161
Reduced postischemic macrophage infiltration and interstitial fibrosis in osteopontin knockout mice
Persy, V. P., Verhulst, A., Ysebaert, D. K., De Greef, K. E., & De Broe, M. E. (2003) · Kidney International · doi:10.1046/j.1523-1755.2003.00767.x · Cited by 158
ACE2, angiotensin-(1–7), and Mas: the other side of the coin
Bader, M. (2013) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-012-1120-0 · Cited by 158
Iglarz, M., Touyz, R. M., Viel, É. C., Amiri, F., & Schiffrin, E. L. (2004) · PubMed · Cited by 158
Nagase, M., Matsui, H., Shibata, S., Gotoda, T., & Fujita, T. (2007) · Hypertension · doi:10.1161/hypertensionaha.107.091058 · Cited by 157
Baroreflex sensitivity and cardiovascular mortality in patients with mild to moderate heart failure.
Osterziel, K. J., Hänlein, D., Willenbrock, R., Eichhorn, C., Luft, F. C., & Dietz, R. (1995) · Heart · doi:10.1136/hrt.73.6.517 · Cited by 155
The BENCH (BENazepril in Canine Heart disease) Study Group (1999) · Journal of Veterinary Cardiology · doi:10.1016/s1760-2734(06)70025-x · Cited by 155
Sato, A., & Saruta, T. (2001) · Journal of International Medical Research · doi:10.1177/147323000102900103 · Cited by 148
VASCULAR TYPE I ALDOSTERONE BINDING SITES ARE PHYSIOLOGICAL MINERALOCORTICOID RECEPTORS
Funder, J. W., Pearce, P., Smith, R., & Campbell, J. H. (1989) · Endocrinology · doi:10.1210/endo-125-4-2224 · Cited by 144
Long-term effects of antihypertensive regimens on renal hemodynamics and proteinuria
Brown, S. A., Walton, C., Crawford, P., & Bakris, G. L. (1993) · Kidney International · doi:10.1038/ki.1993.171 · Cited by 143
Expression of the mouse and rat mas proto‐oncogene in the brain and peripheral tissues
Metzger, R., Bäder, M., Ludwig, T., Berberich, C. E., Bunnemann, B., & Ganten, D. (1995) · FEBS Letters · doi:10.1016/0014-5793(94)01292-9 · Cited by 143
Aldosterone enhances angiotensin II receptor binding and inositol phosphate responses.
Ullian, M. E., Schelling, J. R., & Linas, S. L. (1992) · Hypertension · doi:10.1161/01.hyp.20.1.67 · Cited by 141
Ettinger, S. J., Benitz, A. M., Ericsson, G. F., et al. (1998) · PubMed · Cited by 139
Woodfield, J. A. (1995) · Journal of Veterinary Internal Medicine · doi:10.1111/j.1939-1676.1995.tb01075.x · Cited by 139
Atkins, C. E., Keene, B. W., Brown, W. A., Coats, J. R., Crawford, M. A., DeFrancesco, T. C., Edwards, N. J., Fox, P. R., Lehmkuhl, L. B., Luethy, M. W., et al. (2007) · Journal of the American Veterinary Medical Association · doi:10.2460/javma.231.7.1061 · Cited by 137
Self-citationCicoira, M., Zanolla, L., Rossi, A., Golia, G., Franceschini, L., Cabrini, G., Bonizzato, A., Graziani, M., Anker, S. D., Coats, A. J. S., et al. (2001) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(01)01237-2 · Cited by 137
van de Wal, R. M. A., Plokker, H. W. M., Lok, D. J. A., Boomsma, F., van der Horst, F. A. L., van Veldhuisen, D. J., van Gilst, W. H., & Voors, A. A. (2005) · International Journal of Cardiology · doi:10.1016/j.ijcard.2005.02.016 · Cited by 135
Stewart, J. A. (2003) · Journal of Molecular and Cellular Cardiology · doi:10.1016/s0022-2828(03)00013-0 · Cited by 134
Praga, M., Hernández, E., Montoyo, C., Andrés, A., Ruilope, L. M., & Rodicio, J. L. (1992) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(12)80696-2 · Cited by 132
The role of the mineralocorticoid receptor in adipocyte biology and fat metabolism
Marzolla, V., Armani, A., Zennaro, M., Cinti, F., Mammi, C., Fabbri, A., Rosano, G. M. C., & Caprio, M. (2011) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2011.09.011 · Cited by 132
Ando, K., Ohtsu, H., Uchida, S., Kaname, S., Arakawa, Y., & Fujita, T. (2014) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(14)70194-9 · Cited by 130
Bienvenu, L. A., Morgan, J., Rickard, A. J., Tesch, G. H., Cranston, G. A., Fletcher, E. K., Delbridge, L. M. D., & Young, M. J. (2012) · Endocrinology · doi:10.1210/en.2011-2098 · Cited by 130
Effects of enalapril maleate on survival of dogs with naturally acquired heart failure
Ettinger, S. J., Benitz, A. M., Ericsson, G. F., et al. (1998) · Journal of the American Veterinary Medical Association · doi:10.2460/javma.1998.213.11.1573 · Cited by 128
Ortega, T. M., Feldman, E. C., Nelson, R. W., Willits, N. H., & Cowgill, L. D. (1996) · Journal of the American Veterinary Medical Association · doi:10.2460/javma.1996.209.10.1724 · Cited by 127
Chymase-Dependent Generation of Angiotensin II from Angiotensin-(1-12) in Human Atrial Tissue
Ahmad, S., Simmons, T. W., Varagić, J., Moniwa, N., Chappell, M. C., & Ferrario, C. M. (2011) · PLoS ONE · doi:10.1371/journal.pone.0028501 · Cited by 124
Xue, C., & Siragy, H. M. (2005) · Hypertension · doi:10.1161/01.hyp.0000175814.18550.c0 · Cited by 124
Systems analysis of arterial pressure regulation and hypertension
Guyton, A. C., Coleman, T. G., Cowley, A. W., Liard, J.-F., Norman, R. A., & Manning, R. D. (1972) · Annals of Biomedical Engineering · doi:10.1007/bf02584211 · Cited by 122
Mast cells in human and experimental cardiometabolic diseases
Shi, G., Bot, I., & Kovanen, P. T. (2015) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2015.117 · Cited by 122
Kosmala, W., Rojek, A., Przewłocka‐Kosmala, M., Wright, L. M., Mysiak, A., & Marwick, T. H. (2016) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2016.07.763 · Cited by 121
Consensus Recommendations for Standard Therapy of Glomerular Disease in Dogs
IRIS Canine GN Study Group Standard Therapy Subgroup, Brown, S. A., Elliott, J., Francey, T., Polzin, D. J., & Vaden, S. L. (2013) · Journal of Veterinary Internal Medicine · doi:10.1111/jvim.12230 · Cited by 118
Aldosterone reduces baroreceptor discharge in the dog.
Wang, W., McClain, J. M., & Zucker, I. H. (1992) · Hypertension · doi:10.1161/01.hyp.19.3.270 · Cited by 117
Lewis, E. F., Kim, H.-Y., Claggett, B., Spertus, J., Heitner, J. F., Assmann, S. F., Kenwood, C. T., Solomon, S. D., Desai, A. S., Fang, J. C., et al. (2016) · Circulation: Heart Failure · doi:10.1161/circheartfailure.114.001937 · Cited by 114
Self-citationMultifunctional Role of Chymase in Acute and Chronic Tissue Injury and Remodeling
Dell’Italia, L. J., Collawn, J. F., & Ferrario, C. M. (2018) · Circulation Research · doi:10.1161/circresaha.117.310978 · Cited by 113
Angiotensin II–Dependent Superoxide
Welch, W. J. (2008) · Hypertension · doi:10.1161/hypertensionaha.107.090472 · Cited by 111
Jensen, J., Henik, R. A., Brownfield, M. S., et al. (1997) · American Journal of Veterinary Research · doi:10.2460/ajvr.1997.58.05.535 · Cited by 108
Bernay, F., Bland, M., Häggström, J. U., Baduel, L., Combes, B., Lopez, A., & Kaltsatos, V. (2010) · Journal of Veterinary Internal Medicine · doi:10.1111/j.1939-1676.2009.0467.x · Cited by 107
Effects of Enalapril versus Placebo as a Treatment for Canine Idiopathic Glomerulonephritis
Grauer, G. F., Greco, D. S., Getzy, D. M., et al. (2000) · Journal of Veterinary Internal Medicine · doi:10.1111/j.1939-1676.2000.tb02271.x · Cited by 106
Angiotensin AT2 receptors: control of renal sodium excretion and blood pressure
Carey, R. M., & Padia, S. H. (2008) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2008.01.003 · Cited by 103
Flores‐Muñoz, M., Smith, N. J., Haggerty, C., Milligan, G., & Nicklin, S. A. (2010) · The Journal of Physiology · doi:10.1113/jphysiol.2010.203075 · Cited by 101
Sisson, D. D. (1995) · Journal of Veterinary Internal Medicine · doi:10.1111/j.1939-1676.1995.tb01074.x · Cited by 101
Changes in Systolic Blood Pressure over Time in Healthy Cats and Cats with Chronic Kidney Disease
Bijsmans, E. S., Jepson, R. E., Chang, Y., Syme, H. M., & Elliott, J. (2015) · Journal of Veterinary Internal Medicine · doi:10.1111/jvim.12600 · Cited by 101
Perry, G. J., Wei, C., Hankes, G. H., Dillon, S., Rynders, P. E., Mukherjee, R. D., Spinale, F. G., & Dell’Italia, L. J. (2002) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(02)01763-1 · Cited by 100
Jalil, J., Janicki, J. S., Pick, R. L., et al. (1991) · American Journal of Hypertension · doi:10.1093/ajh/4.1.51 · Cited by 98
Tang, W. H. W., Vagelos, R. H., Yee, Y., Benedict, C. R., Willson, K., Liss, C. L., LaBelle, P., & Fowler, M. B. (2002) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(01)01714-4 · Cited by 98
Martino, T. A., Tata, N., Simpson, J. A., Vanderlaan, R., Dawood, F., Kabir, M. G., Khaper, N., Cifelli, C., Podobed, P., Liu, P. P., et al. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2010.11.022 · Cited by 94 · cited 1×
“100,101”
Aldosterone-receptor antagonism in hypertension
Jansen, P. M., Danser, A. J., Imholz, B. P. M., & van den Meiracker, A. H. (2009) · Journal of Hypertension · doi:10.1097/hjh.0b013e32832810ed · Cited by 92
Brown, S. A., Finco, D. R., Brown, C. A., et al. (2003) · American Journal of Veterinary Research · doi:10.2460/ajvr.2003.64.321 · Cited by 86
Ni, W., Zhan, Y., He, H., Maynard, E., Balschi, J. A., & Oettgen, P. (2007) · Circulation Research · doi:10.1161/circresaha.107.152439 · Cited by 84
Mechanisms of escape from sodium retention during angiotensin II hypertension
Hall, J. E., Granger, J. P., Hester, R. L., Coleman, T. G., Smith, M. J., & Cross, R. B. (1984) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.1984.246.5.f627 · Cited by 84
Determinants of the natriuresis after acute, slow sodium loading in conscious dogs
Bie, P., & Sandgaard, N. C. F. (2000) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.2000.278.1.r1 · Cited by 83
Wei, C., Tian, B., Perry, G. J., Meng, Q. C., Chen, Y.-F., Oparil, S., & Dell’Italia, L. J. (2002) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00191.2001 · Cited by 82
Sent, U., Gössl, R., Elliott, J., Syme, H. M., & Zimmering, T. M. (2015) · Journal of Veterinary Internal Medicine · doi:10.1111/jvim.13639 · Cited by 81
Marzolla, V., Armani, A., Feraco, A., Martino, M. U. D., Fabbri, A., Rosano, G. M. C., & Caprio, M. (2014) · Steroids · doi:10.1016/j.steroids.2014.05.001 · Cited by 75
Horita, Y., Taura, K., Taguchi, T., Furusu, A., & Kohno, S. (2006) · Nephrology · doi:10.1111/j.1440-1797.2006.00665.x · Cited by 75
Fuller, P. J., Yang, J., & Young, M. J. (2017) · Journal of Endocrinology · doi:10.1530/joe-17-0060 · Cited by 74
Xavier, F. E., Aras‐López, R., Arroyo-Villa, I., del Campo, L., Salaíces, M., Rossoni, L. V., Ferrer, M., & Balfagón, G. (2008) · British Journal of Pharmacology · doi:10.1038/bjp.2008.200 · Cited by 73
Lee, A. F. C., MacFadyen, R. J., & Struthers, A. D. (1999) · European Journal of Heart Failure · doi:10.1016/s1388-9842(99)00046-x · Cited by 72
O'Grady, M., O’Sullivan, M. L., Minors, S. L., & Horne, R. (2009) · Journal of Veterinary Internal Medicine · doi:10.1111/j.1939-1676.2009.0346.x · Cited by 71
Enalapril Clinical Pharmacokinetics and Pharmacokinetic-Pharmacodynamic Relationships
MacFadyen, R. J., Meredith, P., & Elliott, H. L. (1993) · Clinical Pharmacokinetics · doi:10.2165/00003088-199325040-00003 · Cited by 69
Girerd, N., Pang, P. S., Swedberg, K. B., Fought, A. J., Kwasny, M., Subacius, H. P., Konstam, M. A., Maggioni, A. P., Gheorghiade, M., Zannad, F. M., et al. (2013) · European Journal of Heart Failure · doi:10.1093/eurjhf/hft100 · Cited by 67
Long-term follow-up of acute renal failure caused by angiotensin converting enzyme inhibitors
Wynckel, A., Ebikili, B., Melin, J., Randoux, C., Lavaud, S., & Chanard, J. (1998) · American Journal of Hypertension · doi:10.1016/s0895-7061(98)00117-4 · Cited by 67
Rossier, M. F., Lenglet, S., Vetterli, L., Python, M., & Maturana, A. D. (2008) · Hypertension · doi:10.1161/hypertensionaha.108.114223 · Cited by 66
Detection and Management of Geographic Disparities in the TOPCAT Trial
Bristow, M. R., Enciso, J. S., Gersh, B. J., Grady, C., Rice, M. M., Singh, S. N., Sopko, G. S., Boineau, R., Rosenberg, Y., & Greenberg, B. (2016) · JACC Basic to Translational Science · doi:10.1016/j.jacbts.2016.03.001 · Cited by 65
MacDonald, K. A., Kittleson, M. D., Larson, R. F., Kass, P. H., Klose, T. C., & Wisner, E. R. (2006) · Journal of Veterinary Internal Medicine · doi:10.1111/j.1939-1676.2006.tb00707.x · Cited by 65
Wenger, M., Sieber‐Ruckstuhl, N. S., Müller, C., & Reusch, C. E. (2004) · American Journal of Veterinary Research · doi:10.2460/ajvr.2004.65.1245 · Cited by 64
Goy‐Thollot, I., Péchereau, D., Kéroack, S., et al. (2002) · Journal of Small Animal Practice · doi:10.1111/j.1748-5827.2002.tb00019.x · Cited by 63
Intracrine angiotensin II functions originate from noncanonical pathways in the human heart
Ferrario, C. M., Ahmad, S., Varagić, J., Cheng, C. P., Groban, L., Wang, H., Collawn, J. F., & Dell’Italia, L. J. (2016) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00219.2016 · Cited by 63
Esteghamati, A., Noshad, S., Jarrah, S., Mousavizadeh, M., Khoee, S. H., & Nakhjavani, M. (2013) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gft281 · Cited by 62
Aldosterone impairs baroreflex sensitivity in healthy adults
Monahan, K. D., Leuenberger, U. A., & Ray, C. A. (2006) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00622.2006 · Cited by 62
MacDonald, K. A., Kittleson, M. D., & Kass, P. H. (2008) · Journal of Veterinary Internal Medicine · doi:10.1111/j.1939-1676.2008.0049.x · Cited by 61
Hermida, R. C., Ayala, D. E., Mojón, A., & Fernández, J. R. (2015) · Diabetologia · doi:10.1007/s00125-015-3749-7 · Cited by 60
Butler, J., Ezekowitz, J. A., Collins, S. P., Givertz, M. M., Teerlink, J. R., Walsh, M. N., Albert, N. M., Canary, C. A. W., Carson, P. E., Colvin, M. M., et al. (2012) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2012.02.005 · Cited by 58
Aldosterone synthase inhibitors in hypertension: current status and future possibilities
Hargovan, M., & Ferro, A. (2014) · JRSM Cardiovascular Disease · doi:10.1177/2048004014522440 · Cited by 56
The multifaceted mineralocorticoid receptor
Gomez‐Sanchez, E., & Gomez‐Sanchez, C. E. (2014) · Comprehensive Physiology · doi:10.1002/j.2040-4603.2014.tb00569.x · Cited by 55
Yoneda, T., Takeda, Y., Usukura, M., Oda, N., Takata, H., Yamamoto, Y., Karashima, S., & Yamagishi, M. (2007) · American Journal of Hypertension · doi:10.1016/j.amjhyper.2007.09.001 · Cited by 55
Mello, W. C. D., & Frohlich, E. D. (2014) · Frontiers in Endocrinology · doi:10.3389/fendo.2014.00016 · Cited by 54
Fujita, M., Minamino, T., Asanuma, H., Sanada, S., Hirata, A., Wakeno, M., Myoishi, M., Okuda, H., Ogai, A., Okada, K.-I., et al. (2005) · Hypertension · doi:10.1161/01.hyp.0000171184.84077.80 · Cited by 51
Packer, M., & McMurray, J. J. V. (2016) · The Lancet · doi:10.1016/s0140-6736(16)30969-2 · Cited by 51
Glaus, T. M., Elliott, J., Herberich, E., Zimmering, T. M., & Albrecht, B. (2018) · Journal of Veterinary Internal Medicine · doi:10.1111/jvim.15394 · Cited by 49
Mochel, J. P., Fink, M., Peyrou, M., Désévaux, C., Deurinck, M., Giraudel, J. M., & Danhof, M. (2013) · Chronobiology International · doi:10.3109/07420528.2013.807275 · Cited by 48
Mochel, J. P., Fink, M., Bon, C., Peyrou, M., Bieth, B., Désévaux, C., Deurinck, M., Giraudel, J. M., & Danhof, M. (2014) · Chronobiology International · doi:10.3109/07420528.2014.897711 · Cited by 47
Zheng, J., Wei, C., Hase, N., Shi, K., Killingsworth, C. R., Litovsky, S. H., Powell, P. C., Kobayashi, T., Ferrario, C. M., Rab, A., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0094732 · Cited by 47
INTERACTION OF SPIRONOLACTONE WITH OESTRADIOL RECEPTORS IN CYTOSOL
Levy, J., Burshell, A., Marbach, M., Afllalo, L., & GLICK, S. M. (1980) · Journal of Endocrinology · doi:10.1677/joe.0.0840371 · Cited by 47
Steele, J. L., Henik, R. A., & Stepien, R. L. (2002) · PubMed · Cited by 47
Bomback, A. S., Rekhtman, Y., Klemmer, P. J., Canetta, P. A., Radhakrishnan, J., & Appel, G. B. (2012) · Journal of the American Society of Hypertension · doi:10.1016/j.jash.2012.07.003 · Cited by 46
Atkins, C. E., Brown, W. A., Coats, J. R., Crawford, M. A., DeFrancesco, T. C., Edwards, J., Fox, P. R., Keene, B. W., Lehmkuhl, L. B., Luethy, M. W., et al. (2002) · Journal of the American Veterinary Medical Association · doi:10.2460/javma.2002.221.654 · Cited by 46
Self-citationChronobiological analysis techniques. Application to blood pressure
Fernández, J. R., Hermida, R. C., & Mojón, A. (2008) · Philosophical Transactions of the Royal Society A Mathematical Physical and Engineering Sciences · doi:10.1098/rsta.2008.0231 · Cited by 46
Wang, H., Shimosawa, T., Matsui, H., Kaneko, T., Ogura, S., Uetake, Y., Takenaka, K., Yatomi, Y., & Fujita, T. (2008) · Journal of Hypertension · doi:10.1097/hjh.0b013e328300a232 · Cited by 44
Relationship between proteinuria and progressive renal disease
Walls, J. (2001) · American Journal of Kidney Diseases · doi:10.1053/ajkd.2001.20732 · Cited by 43
Aldosterone, From (Patho)Physiology to Treatment in Cardiovascular and Renal Damage
Waanders, F., de Vries, L. V., van Goor, H., Hillebrands, J., Laverman, G. D., Bakker, S. J. L., & Navis, G. J. (2011) · Current Vascular Pharmacology · doi:10.2174/157016111796642689 · Cited by 41
Cheng, J.-W., Zhang, X., Tian, J., Li, Q., & Chen, J.-M. (2012) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2012.02970.x · Cited by 40
Cardiac macrophages and apoptosis after myocardial infarction: effects of central MR blockade
Rafatian, N., Westcott, K. V., White, R. A., & Leenen, F. H. H. (2014) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00075.2014 · Cited by 39
Tan, J., Wang, J., & Leenen, F. H. H. (2005) · American Journal of Hypertension · doi:10.1016/j.amjhyper.2004.09.004 · Cited by 36
Mochel, J. P., & Danhof, M. (2015) · Reviews of physiology, biochemistry and pharmacology · doi:10.1007/112_2015_27 · Cited by 35
Abraham, P. A. (1988) · Archives of Internal Medicine · doi:10.1001/archinte.148.11.2358 · Cited by 34
Aldosterone Inhibition and Cardiovascular Protection: More Important Than it Once Appeared
Martínez, F. A. (2010) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-010-6256-6 · Cited by 34
Ullian, M. E., & Fine, J. J. (1994) · Journal of Cellular Physiology · doi:10.1002/jcp.1041610203 · Cited by 34
Aldosterone/NaCl-induced renal and cardiac fibrosis is modulated by TGF-β responsiveness of T cells
Schreier, B., Rabe, S., Schneider, B., Ruhs, S., Großmann, C., Hauptmann, S., Blessing, M., Neumann, J., & Gekle, M. (2011) · Hypertension Research · doi:10.1038/hr.2011.16 · Cited by 33
Javadi, S., Kooistra, H. S., Mol, J. A., de Boer, P., Boer, W. H., & Rijnberk, A. (2003) · Veterinary Record · doi:10.1136/vr.153.17.521 · Cited by 33
Cited by
Diabetic Nephropathy: Update on Pillars of Therapy Slowing Progression
Naaman, S. C., & Bakris, G. L. (2023) · Diabetes Care · doi:10.2337/dci23-0030 · Cited by 292
Villaró, S., Jiménez-Márquez, S., Musari, E., Bermejo, R., & Lafarga, T. (2023) · Food Research International · doi:10.1016/j.foodres.2022.112270 · Cited by 50
Metadata
- Authors
- Ames, M. K., Atkins, C. E., & Pitt, B.
- Venue
- Journal of Veterinary Internal Medicine
- Publisher
- Oxford University Press (OUP)
- Published
- 2019-03-01
- Volume
- 33
- Issue
- 2
- Pages
- 363-382
- ISSN
- 0891-6640 (ISSN-L)
- 1939-1676
- OpenAlex
- W2915506231
- Cited by
- 433
- References
- 222
- FWCI
- 28.85
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.